Upgrades
- Vertical Research changed the rating for DuPont de Nemours Inc DD from Hold to Buy. The total market value of DuPont de Nemours's outstanding shares is at $48.8 billion. The stock has a 52-week-high of $85.47 and a 52-week-low of $61.63. DuPont de Nemours's stock last closed at $61.99 per share.
- For Epizyme Inc EPZM, Morgan Stanley upgraded the stock from Equal-Weight to Overweight. In the third quarter, Epizyme showed an EPS of ($0.40), compared to ($0.54) from the year-ago quarter. The current market cap for Epizyme is at $1.0 billion. The stock has a 52-week-high of $17.00 and a 52-week-low of $5.14. Epizyme's stock last closed at $15.30 per share.
- Bank of America upgraded the stock for HCA Healthcare Inc HCA from Neutral to Buy. HCA Healthcare earned $2.23 in the third quarter, compared to $2.16 in the year-ago quarter. The total market value of HCA Healthcare's outstanding shares is at $45.2 billion. The stock has a 52-week-high of $146.96 and a 52-week-low of $110.31. HCA Healthcare's stock last closed at $140.68 per share.
- For Huazhu Group Ltd HTHT, Morgan Stanley upgraded the stock from Underweight to Equal-Weight. In the third quarter, Huazhu Group showed an EPS of $0.20, compared to $0.24 from the year-ago quarter. The total market value of Huazhu Group's outstanding shares is at $11.1 billion. The stock has a 52-week-high of $45.39 and a 52-week-low of $27.01. Huazhu Group's stock last closed at $34.50 per share.
- Wells Fargo changed the rating for Ingersoll-Rand PLC IR from Market Perform to Outperform. For the third quarter, Ingersoll-Rand had an EPS of $1.99, compared to year-ago quarter EPS of $1.75. Ingersoll-Rand's market cap stands at $30.4 billion. The stock has a 52-week-high of $132.42 and a 52-week-low of $85.15. Ingersoll-Rand's stock last closed at $129.02 per share.
- Goldman Sachs changed the rating for Kiniksa Pharmaceuticals Ltd KNSA from Neutral to Buy. In the third quarter, Kiniksa Pharmaceuticals showed an EPS of ($0.49), compared to ($0.51) from the year-ago quarter. Kiniksa Pharmaceuticals's market cap stands at $386.9 million. The stock has a 52-week-high of $28.90 and a 52-week-low of $5.01. Kiniksa Pharmaceuticals's stock last closed at $9.97 per share.
- ScotiaBank changed the rating for Montage Resources Corp MR from Sector Perform to Sector Outperform. The current market cap for Montage Resources is at $161.6 million. The stock has a 52-week-high of $18.60 and a 52-week-low of $2.59. Montage Resources's stock last closed at $5.29 per share.
- Morgan Stanley changed the rating for Royal Philips NV PHG from Equal-Weight to Overweight. For the third quarter, Royal Philips had an EPS of $0.50, compared to year-ago quarter EPS of $0.37. The total market value of Royal Philips's outstanding shares is at $41.6 billion. The stock has a 52-week-high of $48.84 and a 52-week-low of $32.98. Royal Philips's stock last closed at $46.49 per share.
- SVB Leerink changed the rating for Sage Therapeutics Inc SAGE from Underperform to Market Perform. Sage Therapeutics earned ($3.48) in the third quarter, compared to ($2.63) in the year-ago quarter. The current market cap for Sage Therapeutics is at $7.0 billion. The stock has a 52-week-high of $193.56 and a 52-week-low of $56.50. Sage Therapeutics's stock last closed at $60.18 per share.
Downgrades
- Bank of America downgraded the stock for Anthem Inc ANTM from Buy to Neutral. Anthem earned $4.87 in the third quarter, compared to $3.81 in the year-ago quarter. Anthem's market cap stands at $68.2 billion. The stock has a 52-week-high of $317.99 and a 52-week-low of $227.16. Anthem's stock last closed at $286.50 per share.
- Goldman Sachs downgraded the stock for Evoqua Water Technologies Corp AQUA from Buy to Neutral. Evoqua Water Technologies earned $0.01 in the fourth quarter, compared to ($0.03) in the year-ago quarter. The total market value of Evoqua Water Technologies's outstanding shares is at $1.9 billion. The stock has a 52-week-high of $19.79 and a 52-week-low of $9.04. Evoqua Water Technologies's stock last closed at $19.05 per share.
- For Audentes Therapeutics Inc BOLD, JP Morgan downgraded the stock from Overweight to Neutral. Audentes Therapeutics earned ($1.00) in the third quarter, compared to ($0.97) in the year-ago quarter. The current market cap for Audentes Therapeutics is at $1.3 billion. The stock has a 52-week-high of $59.48 and a 52-week-low of $17.95. Audentes Therapeutics's stock last closed at $59.21 per share.
- HSBC downgraded the stock for Borr Drilling Ltd BORR from Buy to Hold. The current market cap for Borr Drilling is at $723.8 million. The stock has a 52-week-high of $16.15 and a 52-week-low of $4.60. Borr Drilling's stock last closed at $6.10 per share.
- Barclays downgraded the stock for Centennial Resource Development Inc CDEV from Overweight to Equal-Weight. For the third quarter, Centennial Resource Dev had an EPS of ($0.01), compared to year-ago quarter EPS of $0.15. The total market value of Centennial Resource Dev's outstanding shares is at $940.9 million. The stock has a 52-week-high of $15.97 and a 52-week-low of $2.92. Centennial Resource Dev's stock last closed at $3.41 per share.
- UBS downgraded the stock for Ciena Corp CIEN from Neutral to Sell. For the third quarter, Ciena had an EPS of $0.71, compared to year-ago quarter EPS of $0.48. Ciena's market cap stands at $5.7 billion. The stock has a 52-week-high of $46.78 and a 52-week-low of $30.67. Ciena's stock last closed at $36.29 per share.
- For Diamond Offshore Drilling Inc DO, HSBC downgraded the stock from Buy to Hold. In the third quarter, Diamond Offshore Drilling showed an EPS of ($0.67), compared to ($0.26) from the year-ago quarter. The total market value of Diamond Offshore Drilling's outstanding shares is at $728.4 million. The stock has a 52-week-high of $12.76 and a 52-week-low of $4.77. Diamond Offshore Drilling's stock last closed at $5.57 per share.
- Barclays changed the rating for Encana Corp ECA from Overweight to Equal-Weight. Encana earned $0.15 in the third quarter, compared to $0.17 in the year-ago quarter. The current market cap for Encana is at $5.0 billion. The stock has a 52-week-high of $7.70 and a 52-week-low of $3.77. Encana's stock last closed at $3.94 per share.
- For TechnipFMC PLC FTI, Jefferies downgraded the stock from Buy to Hold. In the third quarter, TechnipFMC showed an EPS of $0.12, compared to $0.31 from the year-ago quarter. TechnipFMC's market cap stands at $8.3 billion. The stock has a 52-week-high of $28.57 and a 52-week-low of $18.20. TechnipFMC's stock last closed at $18.91 per share.
- For At Home Group Inc HOME, Jefferies downgraded the stock from Buy to Hold. At Home Group earned $0.00 in the third quarter, compared to $0.18 in the year-ago quarter. The current market cap for At Home Group is at $550.0 million. The stock has a 52-week-high of $27.81 and a 52-week-low of $4.58. At Home Group's stock last closed at $5.47 per share.
- Jefferies changed the rating for J.Jill Inc JILL from Buy to Hold. For the third quarter, J.Jill had an EPS of $0.05, compared to year-ago quarter EPS of $0.15. The total market value of J.Jill's outstanding shares is at $76.6 million. The stock has a 52-week-high of $7.51 and a 52-week-low of $1.22. J.Jill's stock last closed at $1.23 per share.
- For The Michaels Companies Inc MIK, Stephens & Co. downgraded the stock from Overweight to Equal-Weight. In the third quarter, Michaels Companies showed an EPS of $0.40, compared to $0.48 from the year-ago quarter. The total market value of Michaels Companies's outstanding shares is at $1.3 billion. The stock has a 52-week-high of $17.27 and a 52-week-low of $4.96. Michaels Companies's stock last closed at $6.08 per share.
- For Noble Corp PLC NE, HSBC downgraded the stock from Buy to Reduce. In the third quarter, Noble showed an EPS of ($0.46), compared to ($0.43) from the year-ago quarter. The current market cap for Noble is at $306.5 million. The stock has a 52-week-high of $4.12 and a 52-week-low of $0.99. Noble's stock last closed at $1.08 per share.
- Loop Capital changed the rating for Ingevity Corp NGVT from Buy to Hold. In the third quarter, Ingevity showed an EPS of $1.46, compared to $1.16 from the year-ago quarter. The total market value of Ingevity's outstanding shares is at $3.5 billion. The stock has a 52-week-high of $120.41 and a 52-week-low of $72.59. Ingevity's stock last closed at $89.81 per share.
- ScotiaBank changed the rating for Range Resources Corp RRC from Sector Outperform to Sector Perform. In the third quarter, Range Resources showed an EPS of ($0.07), compared to $0.26 from the year-ago quarter. The current market cap for Range Resources is at $1.0 billion. The stock has a 52-week-high of $14.56 and a 52-week-low of $3.26. Range Resources's stock last closed at $3.59 per share.
- Ladenburg Thalmann downgraded the stock for Sage Therapeutics Inc SAGE from Buy to Neutral. Sage Therapeutics earned ($3.48) in the third quarter, compared to ($2.63) in the year-ago quarter. The current market cap for Sage Therapeutics is at $7.0 billion. The stock has a 52-week-high of $193.56 and a 52-week-low of $56.50. Sage Therapeutics's stock last closed at $60.18 per share.
Initiations
- With a rating of Market Perform, BMO Capital initiated coverage on Amedisys Inc AMED. The price target is set at $170.00 for Amedisys. In the third quarter, Amedisys showed an EPS of $1.15, compared to $0.95 from the year-ago quarter. The total market value of Amedisys's outstanding shares is at $4.1 billion. The stock has a 52-week-high of $167.37 and a 52-week-low of $103.76. Amedisys's stock last closed at $165.37 per share.
- Goldman Sachs initiated coverage on A.O. Smith Corp AOS with a Sell rating. The price target for A.O. Smith is set at $43.00. In the third quarter, A.O. Smith showed an EPS of $0.53, compared to $0.61 from the year-ago quarter. The total market value of A.O. Smith's outstanding shares is at $8.1 billion. The stock has a 52-week-high of $56.66 and a 52-week-low of $40.38. A.O. Smith's stock last closed at $46.91 per share.
- With a rating of Buy, Goldman Sachs initiated coverage on Armstrong World Industries Inc AWI. The price target is set at $112.00 for Armstrong World Indus. Armstrong World Indus earned $1.38 in the third quarter, compared to $1.11 in the year-ago quarter. The current market cap for Armstrong World Indus is at $4.5 billion. The stock has a 52-week-high of $104.50 and a 52-week-low of $54.34. Armstrong World Indus's stock last closed at $93.24 per share.
- MKM Partners initiated coverage on ConocoPhillips COP with a Buy rating. ConocoPhillips earned $0.82 in the third quarter, compared to $1.36 in the year-ago quarter. The total market value of ConocoPhillips's outstanding shares is at $65.7 billion. The stock has a 52-week-high of $71.01 and a 52-week-low of $50.13. ConocoPhillips's stock last closed at $59.83 per share.
- With a rating of Sell, Goldman Sachs initiated coverage on D.R. Horton Inc DHI. The price target is set at $51.00 for D.R. Horton. For the fourth quarter, D.R. Horton had an EPS of $1.35, compared to year-ago quarter EPS of $1.22. The current market cap for D.R. Horton is at $20.3 billion. The stock has a 52-week-high of $55.81 and a 52-week-low of $32.39. D.R. Horton's stock last closed at $55.75 per share.
- With a rating of Buy, Goldman Sachs initiated coverage on Fortune Brands Home & Security Inc FBHS. The price target is set at $74.00 for Fortune Brands Home. Fortune Brands Home earned $0.95 in the third quarter, compared to $0.93 in the year-ago quarter. The total market value of Fortune Brands Home's outstanding shares is at $8.3 billion. The stock has a 52-week-high of $64.97 and a 52-week-low of $35.27. Fortune Brands Home's stock last closed at $63.90 per share.
- For Fifth Third Bancorp FITB, Odeon Capital initiated coverage, by setting the current rating at Hold. For the third quarter, Fifth Third Bancorp had an EPS of $0.75, compared to year-ago quarter EPS of $0.64. Fifth Third Bancorp's market cap stands at $20.6 billion. The stock has a 52-week-high of $30.89 and a 52-week-low of $22.12. Fifth Third Bancorp's stock last closed at $29.87 per share.
- B. Riley initiated coverage on Federal Home Loan Mortgage Corp FMCC with a Neutral rating. The price target for Federal Home Loan is set at $2.00. Interestingly, in the second quarter, Federal Home Loan's EPS was $0.08. The total market value of Federal Home Loan's outstanding shares is at $1.8 billion. The stock has a 52-week-high of $4.04 and a 52-week-low of $0.98. Federal Home Loan's stock last closed at $2.52 per share.
- Cantor Fitzgerald initiated coverage on Gossamer Bio Inc GOSS with an Overweight rating. The price target for Gossamer Bio is set at $34.00. Gossamer Bio's market cap stands at $1.2 billion. The stock has a 52-week-high of $26.50 and a 52-week-low of $14.49. Gossamer Bio's stock last closed at $24.66 per share.
- With a rating of Buy, Stifel initiated coverage on Chart Industries Inc GTLS. The price target is set at $83.00 for Chart Industries. Chart Industries earned $0.77 in the third quarter, compared to $0.74 in the year-ago quarter. The total market value of Chart Industries's outstanding shares is at $2.0 billion. The stock has a 52-week-high of $95.66 and a 52-week-low of $52.32. Chart Industries's stock last closed at $53.02 per share.
- Goldman Sachs initiated coverage on Installed Building Products Inc IBP with a Neutral rating. The price target for Installed Building Prods is set at $74.00. In the third quarter, Installed Building Prods showed an EPS of $0.99, compared to $0.72 from the year-ago quarter. The total market value of Installed Building Prods's outstanding shares is at $1.9 billion. The stock has a 52-week-high of $76.60 and a 52-week-low of $30.54. Installed Building Prods's stock last closed at $71.82 per share.
- With a rating of Neutral, Goldman Sachs initiated coverage on JELD-WEN Holding Inc JELD. The price target is set at $22.00 for JELD-WEN Holding. In the third quarter, JELD-WEN Holding showed an EPS of $0.26, compared to $0.40 from the year-ago quarter. The current market cap for JELD-WEN Holding is at $1.7 billion. The stock has a 52-week-high of $23.39 and a 52-week-low of $13.28. JELD-WEN Holding's stock last closed at $23.11 per share.
- With a rating of Buy, Goldman Sachs initiated coverage on Lennar Corp LEN. The price target is set at $71.00 for Lennar. In the third quarter, Lennar showed an EPS of $1.59, compared to $1.61 from the year-ago quarter. Lennar's market cap stands at $18.4 billion. The stock has a 52-week-high of $62.63 and a 52-week-low of $37.29. Lennar's stock last closed at $59.80 per share.
- Goldman Sachs initiated coverage on Masco Corp MAS with a Buy rating. The price target for Masco is set at $55.00. Masco earned $0.68 in the third quarter, compared to $0.65 in the year-ago quarter. The current market cap for Masco is at $13.2 billion. The stock has a 52-week-high of $47.51 and a 52-week-low of $27.03. Masco's stock last closed at $46.01 per share.
- SunTrust Robinson Humphrey initiated coverage on MGM Resorts International MGM with a Hold rating. The price target for MGM Resorts Intl is set at $35.00. MGM Resorts Intl earned $0.31 in the third quarter, compared to $0.24 in the year-ago quarter. The current market cap for MGM Resorts Intl is at $14.6 billion. The stock has a 52-week-high of $32.24 and a 52-week-low of $21.61. MGM Resorts Intl's stock last closed at $31.93 per share.
- BTIG initiated coverage on Magenta Therapeutics Inc MGTA with a Buy rating. For the third quarter, Magenta Therapeutics had an EPS of ($0.54), compared to year-ago quarter EPS of ($0.49). Magenta Therapeutics's market cap stands at $405.8 million. The stock has a 52-week-high of $21.00 and a 52-week-low of $5.31. Magenta Therapeutics's stock last closed at $12.98 per share.
- Goldman Sachs initiated coverage on Mohawk Industries Inc MHK with a Buy rating. The price target for Mohawk Industries is set at $165.00. In the third quarter, Mohawk Industries showed an EPS of $2.75, compared to $3.29 from the year-ago quarter. Mohawk Industries's market cap stands at $10.2 billion. The stock has a 52-week-high of $156.60 and a 52-week-low of $108.93. Mohawk Industries's stock last closed at $138.03 per share.
- Goldman Sachs initiated coverage on Meritage Homes Corp MTH with a Sell rating. The price target for Meritage Homes is set at $59.00. Meritage Homes earned $1.79 in the third quarter, compared to $1.33 in the year-ago quarter. Meritage Homes's market cap stands at $2.7 billion. The stock has a 52-week-high of $76.83 and a 52-week-low of $33.57. Meritage Homes's stock last closed at $67.01 per share.
- With a rating of Buy, Goldman Sachs initiated coverage on Owens-Corning Inc OC. The price target is set at $80.00 for Owens-Corning. Owens-Corning earned $1.63 in the third quarter, compared to $1.54 in the year-ago quarter. The current market cap for Owens-Corning is at $6.6 billion. The stock has a 52-week-high of $68.72 and a 52-week-low of $40.64. Owens-Corning's stock last closed at $66.09 per share.
- With a rating of Buy, H.C. Wainwright initiated coverage on Puma Biotechnology Inc PBYI. The price target is set at $15.00 for Puma Biotechnology. In the third quarter, Puma Biotechnology showed an EPS of ($0.44), compared to ($0.37) from the year-ago quarter. The current market cap for Puma Biotechnology is at $264.8 million. The stock has a 52-week-high of $43.90 and a 52-week-low of $6.26. Puma Biotechnology's stock last closed at $7.44 per share.
- With a rating of Buy, Goldman Sachs initiated coverage on PulteGroup Inc PHM. The price target is set at $45.00 for PulteGroup. PulteGroup earned $1.01 in the third quarter, compared to $1.01 in the year-ago quarter. PulteGroup's market cap stands at $10.6 billion. The stock has a 52-week-high of $41.22 and a 52-week-low of $24.45. PulteGroup's stock last closed at $40.21 per share.
- With a rating of Buy, Needham initiated coverage on Rosetta Stone Inc RST. The price target is set at $20.00 for Rosetta Stone. In the third quarter, Rosetta Stone showed an EPS of ($0.12), compared to ($0.31) from the year-ago quarter. Rosetta Stone's market cap stands at $460.9 million. The stock has a 52-week-high of $26.88 and a 52-week-low of $13.76. Rosetta Stone's stock last closed at $15.21 per share.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBuilding ProductsConsumer DiscretionaryHomebuildingIndustrialsInitiationstop upgrades
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in